| Financial Year |
March 31 2023 |
| Monetary Funds |
193,415,425.35 |
| Held-for-trading Financial Assets |
558,464,481.78 |
| Notes Receivable |
735,500.00 |
| Accounts Receivable |
115,508,500.38 |
| Advances to Suppliers |
5,647,602.07 |
| Other Receivables |
5,090,347.02 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,393,553.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
2,084,610.92 |
| Other Current Assets |
-- |
| Total Current Assets |
882,630,303.51 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,224,793.00 |
| Long-term Equity Investment |
21,063,143.17 |
| Investment Properties |
-- |
| Fixed Assetes |
3,273,236.31 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,929,523.51 |
| R&D expenses |
11,639,849.96 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,567,608.12 |
| Deferred Income Tax Assets |
10,905,853.60 |
| Other Non-Current Assets |
15,112.93 |
| Sub-Total of Non-Current Assets |
68,147,793.15 |
| Total Assets |
950,778,096.66 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
5,274,224.64 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,271,911.74 |
| Taxes Payable |
2,285,408.48 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
74,400.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
11,555,697.36 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
38,987,463.64 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
46,448.18 |
| Other Non-Current Liabilities |
2,226,609.69 |
| Sub-Total of Non-Current Liabilities |
4,026,788.04 |
| Total Liabilities |
43,014,251.68 |
| Paid-In Capital(Or Share Stock) |
79,107,000.00 |
| Capital Surplus |
718,187,854.94 |
| Surplus Reserve |
27,190,366.88 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
83,278,623.16 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
907,763,844.98 |
| Owner's Equity（Stockholder's Equity） |
907,763,844.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
950,778,096.66 |
